A decade after Candida auris was discovered, cases have been reported in more than 30 countries around the globe, according to an article on the WPTV website.
To Dr. Tom Chiller, chief of the Centers for Disease Control and Prevention's Mycotic Diseases Branch, the emergence of Candida auris highlights the danger of antimicrobial resistance: the rise of "superbugs."
When it comes to bacteria, drug-resistant infections affect 2 million people a year in the United States, killing at least 23,000, according to the CDC.
And drug-resistant infections more broadly could claim 10 million lives per year around the globe by 2050 -- up from today's 700,000, according to one estimate. "We live in a world covered with antibiotics," Chiller said. "We really need to be thinking hard about how we use those drugs."
Building Envelope Design: Beyond Energy Efficiency
Outpatient Surge Reshapes Long-Term Strategy for Medical Outpatient Buildings
Mercy Medical Center to Be Integrated into Baystate Health
Managing IAQ in Healthcare Facilities During Wildfires
Building Hospital Resilience in an Era of Extreme Weather